Taiyen Biotech Co Ltd
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers beauty and skincare, and cleaning products; salt products; and leisure and pet foods, as well as health supplement. The company was founded in 1952 and is based in Tainan City, Taiwan.
Taiyen Biotech Co Ltd (1737) - Total Liabilities
Latest total liabilities as of December 2025: NT$1.45 Billion TWD
Based on the latest financial reports, Taiyen Biotech Co Ltd (1737) has total liabilities worth NT$1.45 Billion TWD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Taiyen Biotech Co Ltd - Total Liabilities Trend (2003–2025)
This chart illustrates how Taiyen Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Taiyen Biotech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Taiyen Biotech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bhagiradha Chemicals & Industries Limited
NSE:BHAGCHEM
|
India | ₹3.50 Billion |
|
Silicom
NASDAQ:SILC
|
USA | $35.03 Million |
|
Bonduelle S.C.A.
PA:BON
|
France | €1.38 Billion |
|
Shanghai Broadband Technology Co Ltd
SHG:600608
|
China | CN¥78.63 Million |
|
AROAF
PINK:AROAF
|
USA | $14.35 Million |
|
Servotech Power Systems Limited
NSE:SERVOTECH
|
India | ₹2.47 Billion |
|
Apollo Pipes Limited
NSE:APOLLOPIPE
|
India | ₹2.91 Billion |
|
Talga Group Ltd
PINK:TLGRF
|
USA | $6.61 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Taiyen Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Taiyen Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Taiyen Biotech Co Ltd (2003–2025)
The table below shows the annual total liabilities of Taiyen Biotech Co Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$1.45 Billion | -15.45% |
| 2024-12-31 | NT$1.71 Billion | -3.24% |
| 2023-12-31 | NT$1.77 Billion | +14.27% |
| 2022-12-31 | NT$1.55 Billion | -20.70% |
| 2021-12-31 | NT$1.95 Billion | +36.33% |
| 2020-12-31 | NT$1.43 Billion | -1.05% |
| 2019-12-31 | NT$1.45 Billion | +23.77% |
| 2018-12-31 | NT$1.17 Billion | -4.74% |
| 2017-12-31 | NT$1.23 Billion | +15.14% |
| 2016-12-31 | NT$1.07 Billion | +7.77% |
| 2015-12-31 | NT$990.08 Million | +8.42% |
| 2014-12-31 | NT$913.15 Million | +109.12% |
| 2013-12-31 | NT$436.66 Million | +27.49% |
| 2012-12-31 | NT$342.49 Million | -3.94% |
| 2011-12-31 | NT$356.53 Million | -3.47% |
| 2010-12-31 | NT$369.36 Million | +12.23% |
| 2009-12-31 | NT$329.10 Million | +7.40% |
| 2008-12-31 | NT$306.42 Million | -16.72% |
| 2007-12-31 | NT$367.92 Million | -25.99% |
| 2006-12-31 | NT$497.10 Million | -46.31% |
| 2005-12-31 | NT$925.79 Million | -53.50% |
| 2004-12-31 | NT$1.99 Billion | -52.17% |
| 2003-12-31 | NT$4.16 Billion | -- |